Drug
Antihistamines
Antihistamines is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
200%(2 trials)
Phase Distribution
Ph phase_1
1
33%
Ph phase_2
1
33%
Ph phase_4
1
33%
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Completed1
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 21 (33.3%)
Phase 41 (33.3%)
Trials by Status
completed133%
active_not_recruiting133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_4
Steroid Use in Treatment of Allergic Reactions to Food
NCT07341776
active_not_recruitingphase_2
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
NCT01059786
completedphase_1
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
NCT03554473
Clinical Trials (3)
Showing 3 of 3 trials
NCT07341776Phase 4
Steroid Use in Treatment of Allergic Reactions to Food
NCT01059786Phase 2
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
NCT03554473Phase 1
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3